| Financial Year |
March 31 2023 |
| Monetary Funds |
58,196,908.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
88,341,779.95 |
| Advances to Suppliers |
25,796,666.44 |
| Other Receivables |
4,103,195.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,619,745.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,893,692.55 |
| Total Current Assets |
333,951,988.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
119,804,875.38 |
| Investment Properties |
-- |
| Fixed Assetes |
170,179,898.13 |
| Under-construction Projects |
6,422,018.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,921,504.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
44,606.33 |
| Other Non-Current Assets |
20,848,275.11 |
| Sub-Total of Non-Current Assets |
360,405,615.20 |
| Total Assets |
694,357,603.20 |
| Short-Term Loans |
118,940,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
15,114,480.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,188,984.20 |
| Taxes Payable |
115,420.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,697,673.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,145,078.44 |
| Other Current Liabilities |
10,414.06 |
| Sub-Total of Current Liabilities |
164,839,339.60 |
| Long-term Loans |
53,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,719,663.53 |
| Total Liabilities |
218,559,003.13 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
267,802,306.48 |
| Surplus Reserve |
22,813,330.09 |
| LESS:Treasury Stock |
12,495,997.14 |
| Undistributed Profits |
77,507,696.70 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
475,798,600.07 |
| Owner's Equity（Stockholder's Equity） |
475,798,600.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
694,357,603.20 |
